{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T23:03:35Z","timestamp":1744153415866},"reference-count":7,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T00:00:00Z","timestamp":1138147200000},"content-version":"vor","delay-in-days":1911,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2000,11]]},"abstract":"<jats:p><jats:bold>A<jats:sc>bstract<\/jats:sc>: <\/jats:bold><jats:bold> Background: <\/jats:bold> In response to recent reports of mitochondrial dysfunction in HIV\u2010uninfected infants exposed to antiretroviral (ARV) prophylaxis, the Perinatal Safety Review Working Group reviewed deaths in five large HIV\u2010exposed perinatal cohorts in the United States to determine if similar cases of severe mitochondrial toxicity could be detected. We describe the results of this review for the PSD cohort.<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> Hospitalization, clinic and death records for deceased HIV\u2010uninfected and HIV\u2010indeterminate children who were less than 5 years of age were reviewed. Standard definitions were used to classify HIV infection status and the likelihood that signs and symptoms were related to mitochondrial dysfunction. Children were classified as having signs and symptoms that were considered (1) unrelated, (2) unlikely, (3) consistent with, or (4) likely related to mitochondrial disease. SIDS deaths were put into a separate category.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> 8,465 of 13,125 HIV\u2010exposed children were either HIV\u2010uninfected or HIV\u2010indeterminate. Among the 84 deaths in the subgroup of 8,465 children, 9 were considered in Class 2 (unlikely), 4 were considered in Class 3 (consistent with), and none were considered in Class 4 (likely). 97% of those children who received ARV prophylaxis received zidovudine alone. None of the HIV\u2010uninfected deaths were classified in 2, 3, or 4; and only one of these was exposed to ARV prophylaxis. Among the 3 HIV\u2010indeterminate children who were classified in 3 (consistent with), 2 had no or unknown ARV exposure before 1994 when use of ZDV prophylaxis became the standard of care. Both HIV\u2010uninfected and HIV\u2010indeterminate children with ARV exposure or unknown exposure had lower mortality rates than children without ARV exposure.<\/jats:p><jats:p><jats:bold>Conclusion: <\/jats:bold> Monoprophylaxis with ZDV was not associated with higher death rates in the cohort of 8,465 children or with any findings likely consistent with mitochondrial dysfunction among the 85 deaths. Ongoing monitoring of drug safety in large multi\u2010site prospective cohort studies of HIV\u2010exposed children is essential in the era of highly active antiretroviral therapy.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2000.tb05493.x","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T20:18:32Z","timestamp":1279657112000},"page":"236-246","source":"Crossref","is-referenced-by-count":33,"title":["Lack of Definitive Severe Mitochondrial Signs and Symptoms among Deceased HIV\u2010Uninfected and HIV\u2010Indeterminate Children \u2264 5 Years of Age, Pediatric Spectrum of HIV Disease Project (PSD), USA"],"prefix":"10.1111","volume":"918","author":[{"given":"K.","family":"DOMINGUEZ","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"BERTOLLI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"FOWLER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"PETERS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"ORTIZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"MELVILLE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"RAKUSAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"FREDERICK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"HSU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"D'ALMADA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"MALDONADO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"WILFERT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"THE PSD CONSORTIUM, AND THE PERINATAL SAFETY REVIEW WORKING GROUP","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,1,25]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411033311801"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)07219-0"},{"key":"e_1_2_7_4_2","unstructured":"Perinatal Safety Review Working Group. 2000. Absence of clear evidence for mitochondrial disease in children who died before five years of age in five United States cohorts. J. Acquir. Immunodef. Syndr. In press."},{"issue":"4","key":"e_1_2_7_5_2","first-page":"603","article-title":"Biologic, foster, and adoptive parents: caregivers of children exposed perinatally to human immunodeficiency virus in the United States","volume":"90","author":"Caldwell M.B.","year":"1992","journal-title":"The Pediatric Spectrum of Disease Clinical Consortium. Pediatrics"},{"key":"e_1_2_7_6_2","first-page":"29","article-title":"CDC Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome","volume":"48","author":"Centers for Disease Control and Prevention.","year":"1999","journal-title":"M.M.W.R."},{"key":"e_1_2_7_7_2","first-page":"1","article-title":"Recommendations for the use of zidovuding to reduce perinatal transmission of human immunodeficiency virus","volume":"43","author":"Centers for Disease Control and Prevention.","year":"1994","journal-title":"M.M.W.R."},{"key":"e_1_2_7_8_2","unstructured":"Anderson R.N. 1998. United States abriged life tables 1996. Natl. Vital Stat. Rep. 47(13). National Center for Health Statistics. Hyattsville MD."}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2000.tb05493.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2000.tb05493.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T23:27:40Z","timestamp":1695684460000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2000.tb05493.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,11]]}},"alternative-id":["10.1111\/j.1749-6632.2000.tb05493.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2000.tb05493.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"type":"print","value":"0077-8923"},{"type":"electronic","value":"1749-6632"}],"subject":[],"published":{"date-parts":[[2000,11]]}}}